ORCID Profile
0000-0001-7668-2042
Current Organisation
Peter MacCallum Cancer Centre
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: Royal Society of Chemistry (RSC)
Date: 2019
DOI: 10.1039/C8CC07576J
Abstract: Protein–protein interactions control all cellular functions. The designed cyclic peptide LB76 is shown to disrupt key PPI between Hsp90 and co-chaperones. LB76 binds selectively to Hsp90 in the cellular environment and disrupts Hsp90's protein folding activity.
Publisher: American Chemical Society (ACS)
Date: 09-03-2017
Publisher: Royal Society of Chemistry (RSC)
Date: 2015
DOI: 10.1039/C5OB00779H
Abstract: Glucocorticoids form a critical component of chemotherapy regimens for pediatric acute lymphoblastic leukemia and initial poor response to glucocorticoid therapy is predictive of inferior outcome.
Publisher: Informa UK Limited
Date: 2019
Publisher: American Chemical Society (ACS)
Date: 13-12-2018
Publisher: American Chemical Society (ACS)
Date: 26-07-2023
Publisher: Wiley
Date: 09-11-2020
Publisher: Royal Society of Chemistry (RSC)
Date: 2019
DOI: 10.1039/C9CC00890J
Abstract: LB76 is a cyclic peptide that shows great promise as a selective heat shock protein 90 (Hsp90) inhibitor.
No related grants have been discovered for Marwa Nadia Rahimi.